Fertility

How to Research a Fertility Clinic Near You

Save

You cannot vet a fertility clinic from its homepage. The useful signal lives in publicly reported outcome data, in how a clinic staffs and accredits its embryology lab, in whether it pushes unproven add-ons, and in how honestly it quotes success. This guide walks the vetting method step by step, using only the public sources anyone can open.

Last updated: July 2026

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

Where does real fertility clinic data actually live?

Start with the two public data sources, not a clinic's own website. Under the Fertility Clinic Success Rate and Certification Act of 1992, every U.S. clinic performing assisted reproductive technology must report its cycles and outcomes, and the CDC publishes them at national and clinic level 1. The Society for Assisted Reproductive Technology posts a parallel member-clinic report that breaks the same kind of outcomes out by patient age and by cycle 2.

These are the only numbers no clinic wrote for its own brochure. Finding them takes a few minutes and no account: the CDC's ART pages let you look up an individual clinic and see its reported cycles and outcomes, and SART's site lets you pull a clinic's report or the national summary directly 12. Open both before you read a single testimonial or star rating. A clinic that will not point you to its own CDC or SART listing has told you something.

The goal is not to memorize a percentage but to arrive at a consult already knowing roughly what the public record says, so you can ask the clinic why its numbers look the way they do rather than accepting a number it chose to show you. Reading these reports is the whole method of vetting a clinic near you, and the rest of this page is how to read them without being fooled.

The clinic's website is marketing; the CDC and SART reports are the public record.

Why the clinic's headline success rate is not your success rate

A single advertised percentage, 'our success rate is 70%,' is close to meaningless until you know who is counted in it and what event it counts. National data are stratified by age because age is the strongest driver of IVF outcomes, so a clinic's top-line number reflects its mix of patients as much as its skill. The CDC even publishes an IVF Success Estimator that predicts an individual's chance of a live birth from national data using age, height, weight, and diagnosis, and it explicitly applies to ages 20 to 50 and reflects national averages rather than any one clinic's results 3.

Patient selection works quietly. A clinic can raise its headline by steering patients with a poor prognosis toward donor eggs, by declining to treat the most difficult cases, or simply by serving a younger population. None of that is necessarily wrong for the individuals involved, but it means a raw comparison of two clinics' top-line numbers rewards the one with the easier caseload, not the better lab. This is the core of why clinic success rates mislead.

That mismatch has a name: case mix and patient selection. The estimator is useful precisely because it fixes your own characteristics and asks what national data predict, giving you a personal baseline to hold any clinic's claim against 3. case mix is the composition of a clinic's patients, and it can move a headline rate more than the medicine does.

Read the denominator before you read the number

The most important word in any success rate is the one right after 'per.' A live-birth rate per embryo transfer, per intended egg retrieval, and per cycle started describe very different things, and the gap between them can be large. SART reports outcomes several ways, including per intended retrieval, per new patient, and per transfer, with primary, subsequent, and cumulative groupings, precisely so the denominator is visible 2.

This is what people mean by the denominator trap: a rate per transfer has already dropped every cycle that never reached transfer, so it flatters. A simple way to feel the gap is to notice that a clinic which starts many cycles but only reaches transfer in some of them will show a per-transfer rate well above its per-retrieval rate, because everyone who never made it to transfer has been removed from the bottom of the fraction. When a brochure leads with the higher number and omits the lower one, that omission is the message.

When you are comparing clinics, force every number onto the same denominator and the same age band, or you are comparing nothing. Ask for both figures, in your own age band, and the picture stops being flattering and starts being accurate. It also helps to know the difference between national vs clinic data, because a clinic's own report and the national summary answer different questions and should not be read against each other as if they were the same measurement.

The embryology lab is the clinic

Much of what determines an IVF outcome happens in a room the patient never sees: the embryology lab, where eggs are fertilized, embryos are cultured, and everything is frozen and thawed. When you research a clinic, the lab's staffing, accreditation, and track record matter at least as much as the physician's bedside manner. One readable quality signal is how a clinic handles the number of embryos it transfers. Professional guidance favors elective single-embryo transfer, which preserves cumulative live-birth rates while sharply cutting the risk of twins and higher-order multiples 4.

Lab quality is hard to see from outside, so use proxies. Bring a short list of embryology lab questions to the consult: who directs the lab and how long it has been running, what CAP reproductive lab accreditation and CLIA lab standards it holds, whether it uses vitrification for freezing, and how it labels and witnesses samples to prevent mix-ups. It is also fair to ask roughly how many cycles the lab handles a year, since more experience and higher volume can support more consistent results.

The trend toward transferring a single embryo is itself a signal: a lab confident in its culture and freezing can put back one good blastocyst and still expect a strong cumulative result 4. A clinic whose per-transfer number leans on multiple-embryo transfers may be compensating for something, and a high multiple-birth rate can inflate a headline at the cost of riskier pregnancies. A lab confident in its work answers these questions plainly.

Which add-ons is the clinic selling, and do they work?

Fertility clinics increasingly offer 'add-ons' layered onto a standard IVF cycle: extra tests and procedures that raise the price and are marketed as raising your odds. Many have little or no good evidence of benefit, and some may cause harm. The UK's fertility regulator rates these add-ons on a five-tier, color-coded scale, and most of the commonly sold ones, including genetic testing of embryos, assisted hatching, endometrial scratch, and time-lapse imaging, sit in the tiers where evidence of benefit is weak or absent 5.

The pattern to watch is a plan where the add-ons cost nearly as much as the cycle. For each extra, ask what it is meant to do, what a good-quality study says it actually does, and what changes if you decline it. Add-ons are not automatically bad, and a few have specific, legitimate indications; the problem is only when an unproven extra is presented as essential 5.

A good clinic will tell you which parts of its plan are evidence-based and which are optional, and it will be comfortable with you saying no to an unproven extra. That is exactly the kind of thing to raise in your first-consult questions. A standard cycle without add-ons is often the better value, and a clinic that frames every add-on as essential, or implies you are lowering your chances by skipping them, is selling rather than advising.

Vetting the money: packages, refunds, and what is not included

How a clinic prices a full course of care is part of vetting it. Multi-cycle 'risk-sharing' or refund programs can make sense for some patients, but they are only ethical when the clinic defines success in advance, discloses every cost and exclusion such as screening, medications, and storage, and states its own success rates 6. The same ethics analysis flags a built-in conflict of interest, because a program that keeps your money only if you do not succeed can create pressure toward more aggressive treatment 6.

Ask for an itemized estimate of a full cycle and of everything outside the base price: monitoring, anesthesia, medications, genetic testing, and annual storage. Then read what a package excludes before you sign it, and ask what your obligations become if a cycle is cancelled midway.

Because coverage can depend on your state, your employer, and your specific plan, ask the clinic's financial team to run your benefits in writing rather than assuming what is or is not covered. The refund-program caveats matter most for people paying out of pocket, who are also the people such programs are aimed at 6. The brochure sells a feeling; the contract governs what you are actually buying.

Confirm you are seeing a reproductive endocrinologist

The subspecialist who leads IVF care is a reproductive endocrinologist, an OB-GYN with additional fellowship training and board subspecialty certification in reproductive endocrinology and infertility. Confirming that the physician directing your treatment actually holds that certification is a basic, free step, and it is worth knowing what a reproductive endocrinologist actually is before you assume the person you met carries the credential.

Board certification can be verified through the certifying board's public directory, which lists whether a physician holds the subspecialty. A general OB-GYN can offer some fertility care, but the person directing an IVF cycle is where this credential matters most.

The team around the specialist matters too. Day to day, you may interact most with fertility nurses and coordinators, and your embryos are handled by embryologists you never meet; all of them shape your experience and your outcome. Knowing who does what lets you route each question to the person who can answer it, and lets you notice whether the practice is stretched too thin to give your cycle real attention.

A sensible order to do all this in

Put together, the method is a sequence, not a leap, and doing it in order keeps you from being rushed. First, look up the clinic in the public CDC and SART reports and read your own age band on an honest denominator rather than the blended headline 12. Second, note the multiple-birth rate and the single-embryo-transfer rate as lab-quality signals 4. Third, list the add-ons the clinic proposes and check each against the evidence rather than the sales pitch 5.

Then handle the practical layer: get an itemized cost and read any package or refund contract before signing 6, and confirm the physician's board subspecialty certification. Finally, use the consult itself to ask why, not to be told what. Done in that order, you walk in already informed and leave able to decide, instead of deciding under pressure and researching afterward.

Common questions

Two public sources carry them. The CDC publishes ART success-rate data that every U.S. clinic is legally required to report, and SART posts a parallel member-clinic report. Both are searchable and free, and both break outcomes out by patient age. Read them before any clinic's own marketing page.

Not on its own. A clinic that treats younger patients, declines difficult cases, or transfers more embryos can post a higher headline number without delivering better care. Always match the denominator (per retrieval, per transfer, cumulative) and the age band before you compare two clinics, or the comparison means nothing.

Ask who directs the lab and their experience, what accreditations it holds, its freezing and thawing method, and its single-embryo-transfer and multiple-birth rates. The lab does much of the work that determines an outcome, so its answers matter as much as the physician's, even though patients rarely see it.

Most marketed add-ons have weak or no evidence of benefit, and a few may cause harm. Ask the clinic which parts of a proposed plan are evidence-based and which are optional. For many patients a standard cycle without add-ons is the better value and the more honest recommendation.

Look for a reproductive endocrinologist, an OB-GYN with fellowship training and board subspecialty certification in reproductive endocrinology and infertility. Certification can be verified through the certifying board's public directory. Knowing who is directing your care, versus who you happened to meet at intake, lets you direct questions to the right person.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

When fertility treatment becomes urgent

  • —Severe abdominal bloating and pain, rapid weight gain over a day or two, nausea with vomiting, shortness of breath, or urinating much less than usual in the days after an egg retrieval, which can signal ovarian hyperstimulation syndrome
  • —Sharp or one-sided pelvic pain, shoulder-tip pain, dizziness or fainting, or heavy bleeding after a positive pregnancy test, which can signal an ectopic pregnancy
  • —Fever with pelvic pain, or heavy vaginal bleeding, after a retrieval or transfer procedure
  • —Calf swelling and pain, or sudden chest pain and breathlessness, since clot risk is higher during ovarian stimulation

Ovarian hyperstimulation syndrome, ectopic pregnancy, and blood clots are medical emergencies: call 911 or go to the nearest emergency department for severe abdominal pain, breathlessness, fainting, or heavy bleeding, and call your fertility clinic's 24-hour line for anything that worries you.

This article explains how to evaluate a fertility clinic and read publicly reported data. It is educational and is not a substitute for personalized advice from a licensed clinician who knows your history.

References

  1. 1.Centers for Disease Control and Prevention (2024). ART Success Rates. CDC Division of Reproductive Health. linkEstablishes that a 1992 federal law requires U.S. ART clinics to report success rates and that the CDC publishes national and clinic-level data patients can look up.
  2. 2.Society for Assisted Reproductive Technology (SART) (2024). National Summary Report (SART CORS Online). Society for Assisted Reproductive Technology. link ✓Describes how SART reports IVF outcomes by patient age band and by cycle, and the per-retrieval, per-transfer, per-new-patient, and cumulative groupings a reader must distinguish.
  3. 3.Centers for Disease Control and Prevention (2024). IVF Success Estimator. CDC Division of Reproductive Health. linkExplains that individualized IVF live-birth estimates exist for ages 20 to 50 and are based on national averages, not any single clinic's results.
  4. 4.Practice Committees of ASRM and SART (2021). Guidance on the limits to the number of embryos to transfer: a committee opinion. American Society for Reproductive Medicine (Fertility and Sterility). linkSupports that elective single-embryo transfer preserves cumulative live-birth rates while sharply reducing multiple-gestation risk, making a clinic's multiple-birth rate a quality signal.
  5. 5.Human Fertilisation and Embryology Authority (2024). Treatment add-ons with limited evidence. Human Fertilisation and Embryology Authority (UK). link ✓Supports that many marketed IVF add-ons lack good evidence of benefit and some may cause harm, per the HFEA's five-tier color-coded ratings.
  6. 6.Ethics Committee of ASRM (2023). Financial "risk-sharing" or refund programs in assisted reproduction: an Ethics Committee opinion. American Society for Reproductive Medicine (Fertility and Sterility). linkSupports the buyer-beware conditions for IVF refund/risk-sharing programs (predefined success, full cost disclosure, stated clinic success rates) and their conflict-of-interest risk.

6 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — citations link their sources. Editorial policy

← Back to the health library